Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01458587 · ClinicalTrials.gov registry record · Phase 2
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
A Phase 2 study, sponsored by DUSA Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT01458587: Completed Phase 2 study, sponsored by DUSA Pharmaceuticals.
NCT01458587 is a Phase 2 study that has completed, run by DUSA Pharmaceuticals. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01458587, a Phase 2 study, has completed, sponsored by DUSA Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Levulan PDT is safe and effective in the treatment of actinic keratoses on the upper arms and hands.
Primary Outcome
Clearance rate for all lesions
Interventions
- DRUG Aminolevulinic Acid PDT (ALA)
- DRUG Vehicle PDT (VEH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
What the finished NCT01458587 record still lists
NCT01458587 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Aminolevulinic Acid PDT (ALA) is the first listed.
NCT01458587 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01458587 about?
NCT01458587 is a clinical study titled "Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)". The purpose of this study is to determine if Levulan PDT is safe and effective in the treatment of actinic keratoses on the upper arms and hands.
What is the current status of trial NCT01458587?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2011-11. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01458587?
The interventions under investigation include: Aminolevulinic Acid PDT (ALA) (DRUG), Vehicle PDT (VEH) (DRUG).
Who is sponsoring clinical trial NCT01458587?
This trial is sponsored by DUSA Pharmaceuticals, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01458587's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia